Table 4

Mortality and Post-Operative Outcomes for Matched Controls and Major CHD

Controls
(n = 1,272)
Major CHD (n = 1,272)
PatientsPatientsOdds Ratio (95% CI)p ValueRisk Difference (95% CI)
30-day mortality20 (1.6)28 (2.2)1.41 (0.79 to 2.51)0.250.006 (−0.004 to 0.017)
Overall mortality22 (1.7)49 (3.8)2.28 (1.37 to 3.79)0.0020.021 (0.009 to 0.034)
Cardiac arrest6 (0.5)14 (1.1)2.34 (0.90 to 6.13)0.080.006 (−0.001 to 0.013)
Reintubation29 (2.3)69 (5.4)2.46 (1.58 to 3.82)<0.0010.031 (0.017 to 0.046)
Infection70 (5.5)80 (6.3)1.15 (0.83 to 1.60)0.400.008 (−0.010 to 0.026)
Renal failure1 (0.1)4 (0.3)4.01 (0.45 to 35.92)0.220.002 (−0.001 to 0.006)
Neurological failure14 (1.1)14 (1.1)1.00 (0.47 to 2.11)1.000.000 (−0.008 to 0.008)
Thromboembolic complications3 (0.2)2 (0.2)0.67 (0.11 to 3.99)0.66−0.001 (−0.004 to 0.003)
30-day reoperation72 (5.7)95 (7.5)1.34 (0.98 to 1.85)0.070.018 (−0.001 to 0.037)
30-day readmission114 (9.0)106 (8.3)0.92 (0.70 to 1.22)0.57−0.006 (−0.028 to 0.016)

Values are n (%) unless otherwise indicated. p values in bold are Bonferroni-adjusted p ≤ 0.005 used to identify statistically significant differences.

Abbreviations as in Table 3.

  • Includes respiratory, urinary tract, and surgical site infections.